On Tuesday May 31, 2022, Unilever named American activist investor Nelson Peltz as a board member. Peltz who currently holds a generally 1.5% stake in the customer goods giant has been included in the leading team of the outfit.
London-Listed Unilever said Peltz will join as a non-executive director from July 2022 and act as a member from the board’s remuneration panel.
Peltz’s hedge fund Trian Fund Management manages funds with interests in about 37.4 million Unilever shares, or 1.5% of the British firm, as per the company.
“We look forward to working collaboratively with management and the Board to help drive Unilever’s strategy, operations, sustainability, and shareholder value,” Peltz said in a statement.
His appointment comes months after news that he had built a stake in Unilever, whose methodology was under a microscope this year after a brief quest for GSK’s consumer medical services arm.
As per Unilever Chair Nils Andersen, the company has held an extensive and useful conversations with him and the Trian group and believe that Nelson’s experience with the global purchaser goods industry will be of worth to the organization.
The organization’s fruitless 50-billion-pound ($63-billion) quest for GSK’s buyer wellbeing business had brought up issues about Unilever’s plans under Chief Executive Officer Alan Jope.
Nelson Peltz is an American billionaire businessman and investor. The 79 year old is a founding partner, together with Peter W. May and Edward P. Garden, of Trian Fund Management, an alternative investment management fund based in New York. As at now (2022), Peltz is Net worth 1.6 billion USD, as per Forbes.